1. Home
  2. BXMT vs PTGX Comparison

BXMT vs PTGX Comparison

Compare BXMT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BXMT
  • PTGX
  • Stock Information
  • Founded
  • BXMT 1966
  • PTGX 2006
  • Country
  • BXMT United States
  • PTGX United States
  • Employees
  • BXMT N/A
  • PTGX N/A
  • Industry
  • BXMT Real Estate Investment Trusts
  • PTGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BXMT Real Estate
  • PTGX Health Care
  • Exchange
  • BXMT Nasdaq
  • PTGX Nasdaq
  • Market Cap
  • BXMT 3.0B
  • PTGX 2.8B
  • IPO Year
  • BXMT N/A
  • PTGX 2016
  • Fundamental
  • Price
  • BXMT $18.77
  • PTGX $41.65
  • Analyst Decision
  • BXMT Buy
  • PTGX Strong Buy
  • Analyst Count
  • BXMT 9
  • PTGX 7
  • Target Price
  • BXMT $20.36
  • PTGX $53.57
  • AVG Volume (30 Days)
  • BXMT 1.4M
  • PTGX 700.6K
  • Earning Date
  • BXMT 10-23-2024
  • PTGX 11-07-2024
  • Dividend Yield
  • BXMT 12.41%
  • PTGX N/A
  • EPS Growth
  • BXMT N/A
  • PTGX N/A
  • EPS
  • BXMT N/A
  • PTGX 2.68
  • Revenue
  • BXMT N/A
  • PTGX $323,795,000.00
  • Revenue This Year
  • BXMT N/A
  • PTGX $396.93
  • Revenue Next Year
  • BXMT N/A
  • PTGX N/A
  • P/E Ratio
  • BXMT N/A
  • PTGX $15.15
  • Revenue Growth
  • BXMT 1.04
  • PTGX 125.73
  • 52 Week Low
  • BXMT $16.53
  • PTGX $16.80
  • 52 Week High
  • BXMT $23.29
  • PTGX $48.89
  • Technical
  • Relative Strength Index (RSI)
  • BXMT 54.89
  • PTGX 41.01
  • Support Level
  • BXMT $17.76
  • PTGX $33.31
  • Resistance Level
  • BXMT $19.38
  • PTGX $48.86
  • Average True Range (ATR)
  • BXMT 0.41
  • PTGX 2.82
  • MACD
  • BXMT 0.02
  • PTGX -0.62
  • Stochastic Oscillator
  • BXMT 62.35
  • PTGX 53.63

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is a real estate finance company primarily involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A significant percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: